Skip to main content

Methocarbamol

NDC 87441-057 · Unit Dose Solutions, Inc.

Generic nameMethocarbamol
Dosage formTABLET
RouteORAL
Active ingredient(s)METHOCARBAMOL
Strength500 mg/1
Pharmacologic classCentrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]
Marketing categoryANDA

Packages

87441-057-01 — 30 TABLET in 1 BLISTER PACK (87441-057-01)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

82804-121 — methocarbamol, 82804-273 — methocarbamol, 82804-954 — methocarbamol, 82804-955 — methocarbamol, 82982-038 — Methocarbamol Tablets, 85477-101 — Methocarbamol, 85509-1341 — Methocarbamol, 85509-1770 — Methocarbamol Tablets, 85509-1910 — methocarbamol, 85509-2910 — methocarbamol, 85534-0021 — methocarbamol, 85534-0022 — methocarbamol, 85534-0057 — methocarbamol, 85766-060 — Methocarbamol, 86211-114 — Methocarbamol, 87063-040 — Methocarbamol, 87063-041 — Methocarbamol, 87063-135 — methocarbamol, 87063-689 — methocarbamol, 87441-086 — Methocarbamol Tablets, +188 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels